Juvelook Pdlla + Ha - 1 X 200mg PllA ha PLA Lactide Application Around
We also have a variety of hyaluronic acid products, Solubile product,, Micro Cannula, etc. Welcome to your consultation.
Juvelook is a hybrid filler that combines both the benefits of an immediate filling effect, resulting from the use of HA hyaluronic acid, and long-term stimulation of collagen production, thanks to the use of polylactic acid PDLLA (Poly D, L - lactide)
Thanks to the patented production technology, a preparation with unique properties has been created: long-term effectiveness and an increased safety profile.
Intended use:
Shadows under the eyes
Volume loss in the lower eyelid area
Marked valley of tears
Flaccidity of the skin of the neck, skin of the hands, skin of the face
Brightening and firming the skin
Rejuvenation of the eye area
Wrinkle smoothing
Permanent tension and nourishment of the skin
Areas of application:
eye area: lower eyelid, crow's feet, tear trough
forehead
skin mesotherapy: face, neck and cleavage
Therapy effects
The effects of therapy are visible immediately after administration. We obtain the effect of filling thanks to the presence of hyaluronic acid. After about 2 weeks, collagen production begins with the presence of PDLLA lactic acid microparticles. The effects of the therapy last for more than two years after the last treatment. The recommended number of treatments is 2 or 3 depending on the skin defect at 6-8 week intervals. After two years, it is recommended to perform 1 booster treatment.
Injection methods:
It is administered with a thin 27 g cannula in the area of the lower eyelid or with thin needles, e.g. 31 G, making injections into the lower part of the dermis to a depth of about 1.7 mm.
Strengths of JUVELOOK:
the world's only Poly D,L Lactyd + HA hybrid formula
effectiveness and safety confirmed by clinical trials
durability of the effects - more than 2 years from the last treatment
immediate effect - due to hyaluronic acid
safety - FDA, CE certificates for polylactic acid
patents and own clinical trials
comfort of the procedure - ease of injection and no needle clogging during the procedure
Composition
Polylactic acid (PDLLA - Poly D, L Lactyd) 170 mg
Non-crosslinked hyaluronic acid 30 mg
Audited Supplier 
){kind=link}